Prostate cancer in the senior men from rural areas in east district of China: Contemporary management and 5-year outcomes at multi-institutional collaboration-Reference-Cited by-同舟云学术

Prostate cancer in the senior men from rural areas in east district of China: Contemporary management and 5-year outcomes at multi-institutional collaboration

Published:2012-02 Issue:2 Volume:315 Page:170-177
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Shao Qiang,Ouyang Jun,Fan Youzhang,Xie Jianjun,Zhou Jundong,Wu Jingchang,Karim Kader A.,Xu Jianfeng,Liu Guihua,Shan Yuxi,Wen Duangai,Zhang Yuanyuan

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference21 articles.

1. Management of prostate cancer in China: a multicenter report of 6 institutions;Peyromaure;J. Urol.,2005

2. Guideline of Chinese urological disease diagnosis and treatment;Na,2009

3. GLOBOCAN 2002 cancer incidence, mortality and prevalence worldwide;Ferlay;Cancer J. Clin.,2005

4. Prospective and retrospective analysis on prevalence and tendency of PCa;Ye;China Oncol.,2007

5. Epidemiology of PCa and prevalence tendency in China;Ye;Chin. J. Surg.,2006

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Validation of a Machine Learning Model for Bone Metastasis in Prostate Cancer: Based on Inflammatory and Nutritional Indicators;Urology;2024-08

2. Development and validation of a machine learning model for bone metastasis in prostate cancer: Based on inflammatory and nutritional indicators;2023-07-26

3. Trend in research of prostate cancer bone metastases: A bibliometric analysis from 1992 to 2021;Asian Journal of Surgery;2022-10

4. Different Trends in the Incidence and Mortality Rates of Prostate Cancer Between China and the USA: A Joinpoint and Age-Period-Cohort Analysis;Frontiers in Medicine;2022-02-03

5. Urban–Rural Differences in Clinical Characteristics of Prostate Cancer at Initial Diagnosis: A Single-Center Observational Study in Anhui Province, China;Frontiers in Oncology;2021-08-03